Literature DB >> 17805309

Neuroplasticity of neocortical circuits in schizophrenia.

David A Lewis1, Guillermo González-Burgos.   

Abstract

The core features of schizophrenia include deficits in cognitive processes mediated by the circuitry of the dorsolateral prefrontal cortex (DLPFC). These deficits are associated with a range of molecular and morphological alterations in the DLPFC, each of which could be a cause, consequence, or compensation in relation to other changes, and thus reflect the neuroplasticity of the brain in response to the underlying disease process. In this review, we consider disturbances in excitatory, inhibitory, and modulatory connections of DLPFC circuitry from the perspective of disease- and development-related neuroplasticity and discuss their implications for the identification of novel therapeutic targets.

Entities:  

Mesh:

Year:  2007        PMID: 17805309     DOI: 10.1038/sj.npp.1301563

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  167 in total

1.  Severe cross-modal object recognition deficits in rats treated sub-chronically with NMDA receptor antagonists are reversed by systemic nicotine: implications for abnormal multisensory integration in schizophrenia.

Authors:  Derek L Jacklin; Amit Goel; Kyle J Clementino; Alexander W M Hall; John C Talpos; Boyer D Winters
Journal:  Neuropsychopharmacology       Date:  2012-06-06       Impact factor: 7.853

Review 2.  GABAergic interneuron origin of schizophrenia pathophysiology.

Authors:  Kazu Nakazawa; Veronika Zsiros; Zhihong Jiang; Kazuhito Nakao; Stefan Kolata; Shuqin Zhang; Juan E Belforte
Journal:  Neuropharmacology       Date:  2011-01-26       Impact factor: 5.250

3.  SH3 domain-based phototrapping in living cells reveals Rho family GAP signaling complexes.

Authors:  Hirokazu Okada; Akiyoshi Uezu; Frank M Mason; Erik J Soderblom; M Arthur Moseley; Scott H Soderling
Journal:  Sci Signal       Date:  2011-11-29       Impact factor: 8.192

Review 4.  Pharmacologically-mediated reactivation and reconsolidation blockade of the psychostimulant-abuse circuit: a novel treatment strategy.

Authors:  Tong H Lee; Steven T Szabo; J Corey Fowler; Paolo Mannelli; O Barry Mangum; Wayne F Beyer; Ashwin Patkar; William C Wetsel
Journal:  Drug Alcohol Depend       Date:  2012-02-21       Impact factor: 4.492

5.  Lamina-specific alterations in cortical GABA(A) receptor subunit expression in schizophrenia.

Authors:  Monica Beneyto; Andrew Abbott; Takanori Hashimoto; David A Lewis
Journal:  Cereb Cortex       Date:  2010-09-15       Impact factor: 5.357

6.  Schizophrenia: The making of a troubled mind.

Authors:  David Dobbs
Journal:  Nature       Date:  2010-11-11       Impact factor: 49.962

Review 7.  Epigenetic GABAergic targets in schizophrenia and bipolar disorder.

Authors:  A Guidotti; J Auta; Y Chen; J M Davis; E Dong; D P Gavin; D R Grayson; F Matrisciano; G Pinna; R Satta; R P Sharma; L Tremolizzo; P Tueting
Journal:  Neuropharmacology       Date:  2010-11-11       Impact factor: 5.250

8.  Prenatal ethanol exposure disrupts intraneocortical circuitry, cortical gene expression, and behavior in a mouse model of FASD.

Authors:  Hani El Shawa; Charles W Abbott; Kelly J Huffman
Journal:  J Neurosci       Date:  2013-11-27       Impact factor: 6.167

Review 9.  Hippocampal dysfunction and disruption of dopamine system regulation in an animal model of schizophrenia.

Authors:  Daniel J Lodge; Anthony A Grace
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

10.  Altered parvalbumin basket cell inputs in the dorsolateral prefrontal cortex of schizophrenia subjects.

Authors:  J R Glausier; K N Fish; D A Lewis
Journal:  Mol Psychiatry       Date:  2013-11-12       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.